Aging is one of the strongest risk factors for cardiovascular events and even elderly patients with established disease are likely to derive benefits from secondary prevention programs. Unfortunately, few clinical trials have been specificately addressed to older population. However, since this population is rising and presents with intrinsic characteristics, it is worthwhile to consider the problems of the elderly with a sociological and ethical approach too and not only from a medical point of view.